Platinum in PDB 2i6z: X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme

Enzymatic activity of X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme

All present enzymatic activity of X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme:
3.2.1.17;

Protein crystallography data

The structure of X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme, PDB code: 2i6z was solved by C.Temperini, A.Casini, L.Messori, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

*Resolution Low / High (Å)*	20.00 / 1.90
*Space group*	P 4₃ 2₁ 2
*Cell size a, b, c (Å), α, β, γ (°)*	77.450, 77.450, 37.350, 90.00, 90.00, 90.00
*R / R_free (%)*	18.6 / 24.3

Other elements in 2i6z:

The structure of X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme also contains other interesting chemical elements:

Chlorine

(Cl)

1 atom

Platinum Binding Sites:

The binding sites of Platinum atom in the X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme (pdb code 2i6z). This binding sites where shown within 5.0 Angstroms radius around Platinum atom.
In total only one binding site of Platinum was determined in the X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme, PDB code: 2i6z:

Platinum binding site 1 out of 1 in 2i6z

Go back to

Platinum Binding Sites List in 2i6z

Platinum binding site 1 out of 1 in the X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme

Mono view

Stereo pair view

A full contact list of Platinum with other atoms in the Pt binding site number 1 of X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme within 5.0Å range:

probe	atom	residue	distance (Å)	B	Occ
A:Pt300 b:21.9 occ:0.30	PT1	A:CPT300	0.0	21.9	0.3
	N2	A:CPT300	2.0	21.5	0.3
	N1	A:CPT300	2.0	20.6	0.3
	ND1	A:HIS15	2.1	7.6	1.0
	CE1	A:HIS15	3.0	6.0	1.0
	CG	A:HIS15	3.2	7.1	1.0
	CB	A:HIS15	3.6	7.2	1.0
	CA	A:HIS15	3.7	7.5	1.0
	O	A:HOH554	3.9	10.1	1.0
	NE2	A:HIS15	4.2	7.7	1.0
	CG2	A:THR89	4.2	3.9	1.0
	O	A:HOH574	4.3	19.6	1.0
	CD2	A:HIS15	4.3	6.9	1.0
	O	A:HIS15	4.3	7.8	1.0
	OG1	A:THR89	4.5	4.6	1.0
	C	A:HIS15	4.5	7.6	1.0
	N	A:HIS15	4.7	7.8	1.0
	CB	A:THR89	4.8	4.5	1.0
	O	A:ARG14	4.9	8.1	1.0

Reference:

A.Casini, G.Mastrobuoni, C.Temperini, C.Gabbiani, S.Francese, G.Moneti, C.T.Supuran, A.Scozzafava, L.Messori. Esi Mass Spectrometry and X-Ray Diffraction Studies of Adducts Between Anticancer Platinum Drugs and Hen Egg White Lysozyme. Chem.Commun.(Camb.) 156 2007.
ISSN: ESSN 1364-548X
PubMed: 17180231
DOI: 10.1039/B611122J

Page generated: Wed Dec 16 02:04:01 2020

Last articles

Zn in 7VD8
Zn in 7V1R
Zn in 7V1Q
Zn in 7VPF
Zn in 7T85
Zn in 7T5F
Zn in 7NF9
Zn in 7M4M
Zn in 7M4O
Zn in 7M4N

	© Copyright 2008-2020 by atomistry.com
Home \| Site Map \| Copyright \| Contact us \| Privacy